Bausch Health Companies (BHC) News
NYSE: BHCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
6.040.00 (0.00%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
BHC news summary
We found 2 recent headlines mentioning Bausch Health Companies (BHC): 1 in the past week and 2 in the past 30 days, most often from Nasdaq. For price context, BHC is up 0.00% at $6.04. The most recent story, "The Zacks Analyst Blog Highlights Abbott, Corcept, Precigen and Bausch Health Companies", was published by Nasdaq on Oct 5, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Bausch Health Companies headlines
- The Zacks Analyst Blog Highlights Abbott, Corcept, Precigen and Bausch Health CompaniesHealthcare stocks like Abbott Laboratories offer low-beta exposure as rate hike fears and inflation keep markets volatile.NasdaqABT, CORT, BHC, PGEN
- 4 Low-Beta Healthcare Stocks to Buy Amid Fears of Another Rate HikeABT, CORT, PGEN and BHC offer low-beta healthcare exposure as rate-hike fears and market volatility persist.NasdaqABT, CORT, BHC, PGEN